Melodiol Global Health (ASX:ME1DA) Days Sales Outstanding : 59.05 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Melodiol Global Health Days Sales Outstanding?

Melodiol Global Health's average Accounts Receivable for the six months ended in Dec. 2023 was A$3.86 Mil. Melodiol Global Health's Revenue for the six months ended in Dec. 2023 was A$11.93 Mil. Hence, Melodiol Global Health's Days Sales Outstanding for the six months ended in Dec. 2023 was 59.05.

The historical rank and industry rank for Melodiol Global Health's Days Sales Outstanding or its related term are showing as below:

ASX:ME1DA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 12.77 Med: 90.1 Max: 14919.38
Current: 62.09

During the past 8 years, Melodiol Global Health's highest Days Sales Outstanding was 14919.38. The lowest was 12.77. And the median was 90.10.

ASX:ME1DA's Days Sales Outstanding is ranked better than
59.5% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs ASX:ME1DA: 62.09

Melodiol Global Health's Days Sales Outstanding declined from Dec. 2022 (83.63) to Dec. 2023 (59.05).

Melodiol Global Health Days Sales Outstanding Historical Data

The historical data trend for Melodiol Global Health's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Days Sales Outstanding Chart

Melodiol Global Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

102.37

77.83

12.77

49.30

47.41

Melodiol Global Health Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial										75.10	52.34	83.63	87.14	59.05

Competitive Comparison of Melodiol Global Health's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Melodiol Global Health's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's Days Sales Outstanding falls into.

Melodiol Global Health Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Melodiol Global Health's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.939	+	2.976)	/	2 )	/	18.921	*	365
=	2.4575					/	18.921	*	365
=	47.41

Melodiol Global Health's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4.741	+	2.976)	/	2 )	/	11.926	*	365 / 2
=	3.8585					/	11.926	*	365 / 2
=	59.05

Melodiol Global Health (ASX:ME1DA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Melodiol Global Health Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Melodiol Global Health (ASX:ME1DA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

COPHF:USA

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.cresopharma.com

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DA) Headlines

No Headlines